Allo-HSCT as First-line Consolidation in High-risk PTCL
NCT03672084
·
clinicaltrials.gov ↗
UNKNOWN
Status
50
Enrollment
OTHER
Sponsor class
Conditions
T Cell Lymphoma
Sponsor
Peking University People's Hospital